Korean J Thorac Cardiovasc Surg.  2010 Oct;43(5):499-505.

Expression of CD40, CD86, and HLA-DR in CD1c+ Myeloid Dendritic Cells Isolated from Peripheral Blood in Primary Adenocarcinoma of Lung

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Korea.
  • 2Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Korea. chkang@snu.ac.kr

Abstract

BACKGROUND
There have been several reports using animal experiments that CD1-restricted T-cells have a key role in tumor immunity. To address this issue, we studied the expression of markers for CD1c+ myeloid dendritic cells (DCs) isolated from peripheral blood in the clinical setting. MATERIAL AND METHOD: A total of 24 patients with radiologically suspected or histologically confirmed lung cancer who underwent pulmonary resection were enrolled in this study. The patients were divided according to histology findings into three groups: primary adenocarcinoma of lung (PACL), primary squamous cell carcinoma of lung (PSqCL) and benign lung disease (BLD). We obtained 20 mL of peripheral venous blood from patients using heparin-coated syringes. Using flow-cytometry after labeling with monoclonal antibodies, data acquisition and analysis were done. RESULT: The ratio of CD1c+CD19- dendritic cells to CD1c+ dendritic cells were not significantly different between the three groups. CD40 (p=0.171), CD86 (p=0.037) and HLA-DR (p=0.036) were less expressed in the PACL than the BLD group. Expression of CD40 (p=0.319), CD86 (p=0.036) and HLA-DR (p=0.085) were less expressed in the PACL than the PSqCL group, but the differences were only significant for CD86. Expression of co-stimulatory markers was not different between the PSqCL and BLD groups. Expression of markers for activated DCs were dramatically lower in the PACL group than in groups with other histology (CD40 (p=0.005), CD86 (p=0.013) HLA-DR (p=0.004).
CONCLUSION
These results suggest the possibility that CD1c+ myeloid DCs participate in control of the tumor immunity system and that low expression of markers results in lack of an immune response triggered by dendritic cells in adenocarcinoma of the lung.

Keyword

Immunology; Adenocarcinoma; Lung neoplasm; Dendritic cells; Antigens

MeSH Terms

Adenocarcinoma
Animal Experimentation
Antibodies, Monoclonal
Carcinoma, Squamous Cell
Dendritic Cells
HLA-DR Antigens
Humans
Lung
Lung Diseases
Lung Neoplasms
Syringes
T-Lymphocytes
Adenocarcinoma
Antibodies, Monoclonal
HLA-DR Antigens
Lung Neoplasms
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr